본문 바로가기
KERD
논문KCI 등재

Declined Preoperative Aspartate Aminotransferase to Neutrophil Ratio Index Predicts Poor Prognosis in Patients with Intrahepatic Cholangiocarcinoma after Hepatectomy

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose Various inflammation-based prognostic biomarkers such as the platelet to lymphocyte ratio and neutrophil to lymphocyte ratio, are related to poor survival in patients with intrahepatic cholangiocarcinoma (ICC). This study aims to investigate the prognostic value of the aspartate aminotransferase to neutrophil ratio index (ANRI) in ICC after hepatic resection. Materials and Methods Data of 184 patients with ICC after hepatectomy were retrospectively reviewed. The cut-off value of ANRI was determined by a receiver operating characteristic curve. Preoperative ANRI and clinicopathological variables were analyzed. The predictive value of preoperative ANRI for prognosis of ICC was identified by univariate and multivariate analyses. Results The optimal cut-off value of ANRI was 6.7. ANRI was associated with tumor size, tumor recurrence, white blood cell, neutrophil count, aspartate aminotransferase, and alanine transaminase. Univariate analysis showed that ANRI, sex, tumor number, tumor size, tumor differentiation, lymph node metastasis, resection margin, clinical TNM stage, neutrophil count, and carcinoembryonic antigen were markedly correlated with overall survival (OS) and disease-free survival (DFS) in patients with ICC. Multivariable analyses revealed that ANRI, a tumor size > 6 cm, poor tumor differentiation, and an R1 resection margin were independent prognostic factors for both OS and DFS. Additionally, preoperative ANRI also had a significant value to predict prognosis in various subgroups of ICC, including serum hepatitis B surface antigennegative and preoperative elevated carbohydrate antigen 19-9 patients. Conclusion Preoperative declined ANRI is a noninvasive, simple, and effective predictor of poor prognosis in patients with ICC after hepatectomy.

Abstract

Purpose Various inflammation-based prognostic biomarkers such as the platelet to lymphocyte ratio and neutrophil to lymphocyte ratio, are related to poor survival in patients with intrahepatic cholangiocarcinoma (ICC). This study aims to investigate the prognostic value of the aspartate aminotransferase to neutrophil ratio index (ANRI) in ICC after hepatic resection. Materials and Methods Data of 184 patients with ICC after hepatectomy were retrospectively reviewed. The cut-off value of ANRI was determined by a receiver operating characteristic curve. Preoperative ANRI and clinicopathological variables were analyzed. The predictive value of preoperative ANRI for prognosis of ICC was identified by univariate and multivariate analyses. Results The optimal cut-off value of ANRI was 6.7. ANRI was associated with tumor size, tumor recurrence, white blood cell, neutrophil count, aspartate aminotransferase, and alanine transaminase. Univariate analysis showed that ANRI, sex, tumor number, tumor size, tumor differentiation, lymph node metastasis, resection margin, clinical TNM stage, neutrophil count, and carcinoembryonic antigen were markedly correlated with overall survival (OS) and disease-free survival (DFS) in patients with ICC. Multivariable analyses revealed that ANRI, a tumor size > 6 cm, poor tumor differentiation, and an R1 resection margin were independent prognostic factors for both OS and DFS. Additionally, preoperative ANRI also had a significant value to predict prognosis in various subgroups of ICC, including serum hepatitis B surface antigennegative and preoperative elevated carbohydrate antigen 19-9 patients. Conclusion Preoperative declined ANRI is a noninvasive, simple, and effective predictor of poor prognosis in patients with ICC after hepatectomy.

참고문헌 (21)

  1. Moeini A, "Molecular pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma", Clin Cancer Res, 22, pp.291~300 (2016)[DOI]
  2. Bridgewater J, "Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma", J Hepatol, 60, pp.1268~1289 (2014)[DOI]
  3. Jutric Z, "Impact of lymph node status in patients with intrahepatic cholangiocarcinoma treated by major hepatectomy: a review of the National Cancer Database", HPB (Oxford), 18, pp.79~87 (2016)[DOI]
  4. Spolverato G, "Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection", Ann Surg Oncol, 23, pp.235~243 (2016)[DOI]
  5. Poultsides GA, "Intrahepatic cholangiocarcinoma", Surg Clin North Am, 90, pp.817~837 (2010)[DOI]
  6. Kim HC, "Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study", BMJ, 328, pp.983~ (2004)[DOI]
  7. Fu SJ, "Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy", Med Oncol, 30, pp.721~ (2013)[DOI]
  8. Jin J, "Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection", Oncotarget, 6, pp.19217~19227 (2015)
  9. Ji F, "Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection", Oncotarget, 7, pp.72276~72289 (2016)
  10. Bosman FT, "WHO classification of tumours of the digestive system, 4th ed" (2010), IARC Press
  11. Mantovani A, "Cancer-related inflammation", Nature, 454, pp.436~444 (2008)[DOI]
  12. Nakashima H, "Pre-treatment neutrophil to lymphocyte ratio predicts the chemoradiotherapy outcome and survival in patients with oral squamous cell carcinoma: a retrospective study", BMC Cancer, 16, pp.41~ (2016)[DOI]
  13. 박형순, "Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma", Cancer Research and Treatment, 48(4), pp.1253~1263 (2016), 대한암학회
  14. Zhang L, "Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma", J Surg Oncol, 101, pp.233~238 (2010)[DOI]
  15. Wislez M, "Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death", Cancer Res, 63, pp.1405~1412 (2003)
  16. Houghton AM, "Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth", Nat Med, 16, pp.219~223 (2010)[DOI]
  17. Teramukai S, "Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03", Eur J Cancer, 45, pp.1950~1958 (2009)[DOI]
  18. Zhou SL, "CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils", Carcinogenesis, 35, pp.597~605 (2014)[DOI]
  19. Kusumanto YH, "Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor", Angiogenesis, 6, pp.283~287 (2003)[DOI]
  20. Peng H, "Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma", Oncotarget, 7, pp.17220~17229 (2016)
  21. Khan SA, "Cholangiocarcinoma", Lancet, 366, pp.1303~1314 (2005)[DOI]

관련 논문AI추천

Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent HepatectomyBin Li, Jingxian Shen, Kaiyu Sun, Ming Kuang, Qinghua Cao, Sui Peng, Yifei Wang대한암학회 · Cancer Research and Treatment2019 · 제51권 제4호Blood Neutrophil-to-Lymphocyte Ratio Predicts Tumor Recurrence in Patients with Hepatocellular Carcinoma within Milan Criteria after Hepatectomy김봉완, 박용근, 왕희정, Wei-Guang Xu, Wei Mao, Xu-Guang Hu연세대학교의과대학 · Yonsei Medical Journal2016 · 제57권 제5호Underlying liver disease and advanced stage liver cancer are associated with elevated neutrophil-lymphocyte ratioBrenda Hernandez, Kliment Bozhilov, Linda Wong, Loic LeMarchand, Luke Ellis, Owen Chan, Sandi Kwee대한간학회 · Clinical and Molecular Hepatology2019 · 제25권 제3호Preoperative Prediction Model for Early Recurrence of Intrahepatic Cholangiocarcinoma after Surgical Resection: Development and External Validation Study김동환, 김세희, 박미숙, 박수미, 염석규, 이승수, 이형진, 조은석, 최상현대한암학회 · Cancer Research and Treatment2025 · 제57권 제4호High Systemic Inflammation Response Index (SIRI) Indicates Poor Outcome in Gallbladder Cancer Patients with Surgical Resection: A Single Institution Experience in ChinaBao Jin, Haifeng Xu, Haitao Zhao, Huayu Yang, Lejia Sun, Meixi Liu, Shouxian Zhong, Shunda Du, Wenmo Hu, Xin Lu, Xinting Sang, Yang Chen, Yilei Mao, Yiyao Xu대한암학회 · Cancer Research and Treatment2020 · 제52권 제4호Prognostic impact of hepatitis B or C on intrahepatic cholangiocarcinomaByung Chul Yoo, Byung Soo Kwan, Chan Sup Shim, Jeong Min Yoon, Jung Hoon Lee, Jung Woong Seo, So Young Kwon, Tae Yoon Lee, Won Hyeok Choe, Young Koog Cheon대한내과학회 · The Korean Journal of Internal Medicine2020 · 제35권 제3호

이 간행물의 다른 논문 (29건)